Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-11 Purchase | 2024-06-12 4:30 pm | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 12,509 | $4.4257 | $55,361 | 42,500 (Direct) | View |
2022-11-11 Purchase | 2022-11-14 4:30 pm | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 4,100 | $7.6307 | $31,286 | 17,407 (Direct) | View |
2022-01-14 Purchase | 2022-01-18 7:00 pm | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 10,000 | $8.6767 | $86,767 | 10,000 (Direct) | View |
2021-01-11 Sale | 2021-01-13 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $125.52 | $407,560 | 50,447 (Direct) | View |
2020-11-09 Sale | 2020-11-10 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $74.93 | $121,609 | 27,597 (Direct) | View |
2020-10-07 Sale | 2020-10-09 5:23 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,643 | $74.97 | $797,899 | 63,639 (Direct) | View |
2020-04-20 Sale | 2020-04-22 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 2,000 | $49.79 | $99,580 | 39,419 (Direct) | View |
2020-03-26 Sale | 2020-03-30 4:23 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 5,000 | $48.26 | $241,310 | 41,419 (Direct) | View |
2020-03-02 Sale | 2020-03-04 4:08 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,000 | $52.33 | $156,980 | 46,419 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-31 Option Award | 2024-06-12 4:30 pm | N/A N/A | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 4,448 | $3.7825 | 42,500 (Direct) | View |
2024-01-17 Option Award | 2024-01-18 4:30 pm | N/A 2034-01-16 | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 145,245 | $0 | 145,245 (Direct) | View |
2023-11-30 Option Award | 2023-12-01 5:58 pm | N/A N/A | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 1,345 | $3.7825 | 25,543 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 5:01 pm | N/A N/A | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 4,273 | $3.7825 | 24,198 (Direct) | View |
2023-01-06 Option Award | 2023-01-10 5:00 pm | N/A 2033-01-05 | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 126,300 | $0 | 126,300 (Direct) | View |
2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A N/A | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 2,518 | $3.7825 | 19,925 (Direct) | View |
2022-05-31 Option Award | 2022-06-01 6:00 pm | N/A N/A | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 3,307 | $4.6665 | 13,307 (Direct) | View |
2021-12-04 Option Award | 2021-12-07 5:25 pm | N/A 2031-12-03 | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 144,770 | $0 | 144,770 (Direct) | View |
2021-08-03 Option Award | 2021-08-05 7:25 pm | N/A 2031-07-25 | Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer | 165,000 | $0 | 165,000 (Direct) | View |
2021-01-26 Disposition | 2021-01-28 7:22 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 24,350 | $0 | 0 (Direct) | View |
2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $0 | 50,447 (Direct) | View |
2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $7.24 | 50,447 (Direct) | View |
2020-11-09 Exercise | 2020-11-10 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $0 | 27,597 (Direct) | View |
2020-11-09 Exercise | 2020-11-10 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 1,623 | $7.24 | 27,597 (Direct) | View |
2020-10-07 Exercise | 2020-10-09 5:23 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,199 | $0 | 63,639 (Direct) | View |
2020-10-07 Exercise | 2020-10-09 5:23 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 10,199 | $7.24 | 63,639 (Direct) | View |
2020-05-31 Option Award | 2020-06-05 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 444 | $41.57 | 444 (Direct) | View |
2020-04-20 Exercise | 2020-04-22 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 2,000 | $0 | 39,419 (Direct) | View |
2020-04-20 Exercise | 2020-04-22 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 2,000 | $7.24 | 39,419 (Direct) | View |
2020-03-26 Exercise | 2020-03-30 4:23 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 5,000 | $0 | 41,419 (Direct) | View |
2020-03-26 Exercise | 2020-03-30 4:23 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 5,000 | $7.24 | 41,419 (Direct) | View |
2020-03-02 Exercise | 2020-03-04 4:08 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,000 | $0 | 46,419 (Direct) | View |
2020-03-02 Exercise | 2020-03-04 4:08 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,000 | $7.24 | 46,419 (Direct) | View |
Ownership | 2020-01-09 6:51 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 0 | $0 | 49,419 (Direct) | View |